Recent Insights » Articles » Clinical event adjudication in cardiovascular device trials-FDA Perspective
   

Clinical event adjudication in cardiovascular device trials-FDA Perspective

May 14, 2018
Previous Flipbook
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharrmacologic trials
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharrmacologic trials

Next Flipbook
Use of Endpoint Adjudication to improve the quality and validity of endpoint assessment for Medical Device Development
Use of Endpoint Adjudication to improve the quality and validity of endpoint assessment for Medical Device Development

Request a Genetics in Clinical Trials training session

What You'll Learn
Return to Home